119 related articles for article (PubMed ID: 9693219)
21. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
23. Molecular and structural basis of portal hypertension.
Moreau R; Lebrec D
Clin Liver Dis; 2006 Aug; 10(3):445-57, vii. PubMed ID: 17162222
[TBL] [Abstract][Full Text] [Related]
24. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock.
Yamamoto S; Burman HP; O'Donnell CP; Cahill PA; Robotham JL
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1239-49. PubMed ID: 9087598
[TBL] [Abstract][Full Text] [Related]
25. The pathophysiology of portal hypertension.
Treiber G; Csepregi A; Malfertheiner P
Dig Dis; 2005; 23(1):6-10. PubMed ID: 15920320
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
Geerts AM; Colle I
Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
[No Abstract] [Full Text] [Related]
27. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
28. Splenic neurohormonal modulation of mesenteric vascular tone.
Hamza SM; Kaufman S
Exp Physiol; 2012 Sep; 97(9):1054-64. PubMed ID: 22198012
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
30. Measurement of portal pressure.
Abraldes JG; Sarlieve P; Tandon P
Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
[TBL] [Abstract][Full Text] [Related]
31. Acute-on-chronic liver failure: the liver and portal haemodynamics.
Mookerjee RP
Curr Opin Crit Care; 2011 Apr; 17(2):170-6. PubMed ID: 21346568
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.
Guillaume M; Rodriguez-Vilarrupla A; Gracia-Sancho J; Rosado E; Mancini A; Bosch J; Garcia-Pagán JC
J Hepatol; 2013 Feb; 58(2):240-6. PubMed ID: 22989570
[TBL] [Abstract][Full Text] [Related]
33. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension.
Luca A; Miraglia R; Caruso S; Milazzo M; Gidelli B; Bosch J
Liver Transpl; 2006 Aug; 12(8):1237-43. PubMed ID: 16741929
[TBL] [Abstract][Full Text] [Related]
34. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
[TBL] [Abstract][Full Text] [Related]
35. Expression of endothelin receptors in the gastric mucosa of portal hypertensive rats.
Kai S; Bandoh T; Ohta M; Matsumoto T; Tominaga M; Kitano S
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):242-50. PubMed ID: 16460481
[TBL] [Abstract][Full Text] [Related]
36. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology and a Rational Basis of Therapy.
Gracia-Sancho J; Maeso-Díaz R; Bosch J
Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETA overexpression in portal hypertensive rats.
Chuang CL; Huang HC; Chang CC; Lee FY; Wu JC; Lee JY; Hsieh HG; Lee SD
J Gastroenterol Hepatol; 2015 Jan; 30(1):199-207. PubMed ID: 24989426
[TBL] [Abstract][Full Text] [Related]
39. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
40. Expression of endothelin-1, and endothelin A and B receptors in portal hypertensive esophagus of rats.
Ohta M; Pai R; Kawanaka H; Ma T; Sugimachi K; Sarfeh IJ; Tarnawski AS
J Physiol Pharmacol; 2000 Mar; 51(1):57-67. PubMed ID: 10768851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
